DRL launched four new products in North America during the previous quarter.
Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.
Many are testing hybrid models including getting small batches to work, rotating staff every week, introducing shifts and allowing certain functions to operate from office in small numbers.
A glance back at some of the important ups and down Indian Inc faced in 2018.
Company aims to build five Rs 100 cr-plus brands and launch products from South African arm in domestic market
Sensex rises, Nifty ends at record high; RIL shares rally.
NPPA suggests expanding the list of essential medicines whose prices are controlled
@015 may be a good year for FMCG firms.
Markets rebound with financials leading the gains on hopes of a peaceful solution to the turmoil in Ukraine
It also marks the culmination of the revamp exercise that the brand undertook 18 months back, spearheaded by Nellaiappan Thiruambalam, who was appointed as director and CEO of the personal care and foods division in April 2013.
The benchmark BSE Sensex ended down 2.23 per cent. The Bank Nifty fell 3.59 per cent.
FIIs pump in Rs 2,075 crore in past three trading sessions.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances